ProCE Banner Series

2023 PCE Winter Oncology Conference

PCE, the national leader in continuing education for NPs and PAs, returns in January with our virtual Winter Oncology Conference. This complimentary CE/CME meeting is tailored to meet the clinical needs and evolving scope of practice of NPs, PAs, and nurses who practice in oncology. Live streamed for your convenience and to allow access nationwide. Register now!

  AAPA
  | ANCC
Who Should Attend

Oncology NPs, PAs, and RNs

All Events

PCE Winter Oncology Conference

Past Events

January

28

2023

10:00 AM - 4:05 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Jennifer Bridgeforth-Jackson

Adjunct Professor
School of Business
National Louis University
Chicago, Illinois

ProCE Banner Faculty
Patient Denise Cutlip

ProCE Banner Faculty
Mary Weinstein Dunn, MSN

Nurse Practitioner
Department of Urology and Medicine, Division of Oncology
University of North Carolina Chapel Hill
Chapel Hill, North Carolina

ProCE Banner Faculty
Rasheda Persinger, MSN, AGNP-C, AOCNP

Medical Oncology Lead Nurse Practitioner
Sidney Kimmel Cancer Center Sibley Memorial Hospital
Johns Hopkins System
Washington, DC

ProCE Banner Faculty
Beth Sandy, MSN, CRNP

Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

ProCE Banner Faculty
Laura M. Spring, MD

Breast Medical Oncologist
Mass General Cancer Center
Harvard Medical School
Boston, Massachusetts

ProCE Banner Faculty
Patient Susan Poteat

ProCE Banner Faculty
Sara Tinsley-Vance, PhD, MSN, APRN-BC, AOCN

Nurse Practitioner and Researcher
Malignant Hematology
Moffitt Cancer Center
Tampa, Florida

ProCE Banner Faculty
Sarah Traverso, MMS, PA-C

Physician Assistant
Division of Genitourinary Oncology
Northwestern Medicine
Chicago, Illinois

Topics

Challenges in Myelodysplastic Syndromes (MDS): Risk Stratification and Integrating Novel Treatment Approaches

Improving the Odds in Metastatic Castration-Sensitive Prostate Cancer

Keeping Up With the Rapid Emergence of Strategies for Advanced Renal Cell Carcinoma

Patient and Provider: What Can We Learn From Each Other? 

Biomarker Testing in NSCLC: Who, What, When

Introducing Novel Agents Into the Armamentarium for Triple-Negative Breast Cancer

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Program Overview
PCE, the national leader in continuing education for NPs and PAs, returns in January with our virtual Winter Oncology Conference. This complimentary CE/CME meeting is tailored to meet the clinical needs and evolving scope of practice of NPs, PAs, and nurses who practice in oncology. Live streamed for your convenience and to allow access nationwide.

 

Target Audience
Oncology NPs, PAs, and RNs

 

Titles and Learning Objectives:

 

Challenges in Myelodysplastic Syndromes (MDS): Risk Stratification and Integrating Novel Treatment Approaches
Sara M. Tinsley-Vance, NP
After completing this activity, learners should be better able to:

  • Identify novel and emerging agents for LR- and HR-MDS treatment
  • Plan management strategies for AEs associated with novel therapies for MDS 
  • Integrate patient education and feedback to optimize patient experiences during treatment and survivorship

 

Improving the Odds in Metastatic Castration-Sensitive Prostate Cancer
Sarah Traverso, PA-C
After completing this activity, learners should be better able to:

  • Summarize current guidelines and evidence for treatment of mCSPC
  • Apply strategies to identify and manage treatment-related toxicities in mCSPC
  • Integrate patient education and feedback to optimize patient experiences during treatment and survivorship

 

Keeping Up With the Rapid Emergence of Strategies for Advanced Renal Cell Carcinoma
Mary W. Dunn, MSN, RN, OCN, NP-C
After completing this activity, participants should better be able to:

  • Apply guideline-recommended first- and subsequent-line treatments for advanced RCC
  • Manage AEs of novel therapies for RCC based on guideline recommendations
  • Integrate patient education and feedback to optimize patient experiences during treatment and survivorship

 

Patient and Provider: What Can We Learn From Each Other? 
Denise Cutlip, Susan Poteat; Beth Sandy, NP; Sarah Traverso, PA-C, Jennifer Bridgeforth-Jackson
Bringing together professional and patient learners to hear the faculty and patient panels discuss key learnings and take-home messages from the conference.

  • Integrate patient education and feedback to optimize patient experiences during treatment and survivorship (this one is common to each of the separate topics
  • Identify approaches to affect self-management of care, including adherence and setting life and treatment goals, in conjunction with the oncology healthcare team
  • Identify reliable sources of information and support for care goals

 

Biomarker Testing in NSCLC: Who, What, When?
Rasheda Persinger, MSN
After completing this activity, learners should be better able to:

  • Summarize the most recent guideline-recommended biomarker/molecular testing strategies for NSCLC
  • Formulate evidence-based personalized treatment plans for patients with NSCLC based on actionable biomarkers
  • Integrate patient education and feedback to optimize patient experiences during treatment and survivorship 

 

Introducing Novel Agents Into the Armamentarium for Triple-Negative Breast Cancer
Laura Spring, MD
After completing this activity, learners should be better able to:

  • Differentiate among appropriate treatments for patients with TNBC based on current guidelines and clinical trial evidence
  • Use individualized management strategies for AEs experienced by patients on therapy for TNBC
  • Integrate patient education and feedback to optimize patient experiences during treatment and survivorship

Accreditation


Joint Accreditation Statement


In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


ANCC Credit Designation

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 6.0 contact hours.


AAPA Credit Designation


Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.


IPCE Credit Designation

 

This activity was planned by and for the healthcare team, and learners will receive 6.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

 

Disclosure of Conflicts of Interest 
Partners for Advancing Clinical Education (PACE) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Partners for Advancing Clinical Education (PACE), in partnership with Smart Patients.

This program is supported by educational grants from Amgen, Bayer HealthCare Pharmaceuticals Inc , Exelixis, Inc., Gilead Sciences, Inc., and Karyopharm Therapeutics Inc.